These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 28604104)
1. Intranasal delivery of quercetin-loaded mucoadhesive nanoemulsion for treatment of cerebral ischaemia. Ahmad N; Ahmad R; Naqvi AA; Alam MA; Ashafaq M; Abdur Rub R; Ahmad FJ Artif Cells Nanomed Biotechnol; 2018 Jun; 46(4):717-729. PubMed ID: 28604104 [TBL] [Abstract][Full Text] [Related]
2. Quantification and evaluation of thymoquinone loaded mucoadhesive nanoemulsion for treatment of cerebral ischemia. Ahmad N; Ahmad R; Alam MA; Samim M; Iqbal Z; Ahmad FJ Int J Biol Macromol; 2016 Jul; 88():320-32. PubMed ID: 26976069 [TBL] [Abstract][Full Text] [Related]
3. PNIPAM nanoparticles for targeted and enhanced nose-to-brain delivery of curcuminoids: UPLC/ESI-Q-ToF-MS/MS-based pharmacokinetics and pharmacodynamic evaluation in cerebral ischemia model. Ahmad N; Ahmad I; Umar S; Iqbal Z; Samim M; Ahmad FJ Drug Deliv; 2016 Sep; 23(7):2095-2114. PubMed ID: 25237726 [TBL] [Abstract][Full Text] [Related]
4. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia. Ahmad N; Ahmad R; Naqvi AA; Alam MA; Ashafaq M; Samim M; Iqbal Z; Ahmad FJ Int J Biol Macromol; 2016 Oct; 91():640-55. PubMed ID: 27264648 [TBL] [Abstract][Full Text] [Related]
5. The effect of safranal loaded mucoadhesive nanoemulsion on oxidative stress markers in cerebral ischemia. Ahmad N; Ahmad R; Abbas Naqvi A; Ashafaq M; Alam MA; Ahmad FJ; Al-Ghamdi MS Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):775-787. PubMed ID: 27609117 [TBL] [Abstract][Full Text] [Related]
6. Impact of ultrasonication techniques on the preparation of novel Amiloride-nanoemulsion used for intranasal delivery in the treatment of epilepsy. Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S192-S207. PubMed ID: 30032652 [TBL] [Abstract][Full Text] [Related]
7. Brain-targeted glycyrrhizic-acid-loaded surface decorated nanoparticles for treatment of cerebral ischaemia and its toxicity assessment. Ahmad N; Al-Subaiec AM; Ahmad R; Sharma S; Alam MA; Ashafaq M; Abdur Rub R; Ahmad FJ Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):475-490. PubMed ID: 30739499 [TBL] [Abstract][Full Text] [Related]
8. Poloxamer-chitosan-based Naringenin nanoformulation used in brain targeting for the treatment of cerebral ischemia. Ahmad N; Ahmad R; Ahmad FJ; Ahmad W; Alam MA; Amir M; Ali A Saudi J Biol Sci; 2020 Jan; 27(1):500-517. PubMed ID: 31889876 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of Quercetin Oral Bioavailability by Self-Nanoemulsifying Drug Delivery System and their Quantification Through Ultra High Performance Liquid Chromatography and Mass Spectrometry in Cerebral Ischemia. Ahmad N; Ahmad R; Naqvi AA; Alam MA; Abdur Rub R; Ahmad FJ Drug Res (Stuttg); 2017 Oct; 67(10):564-575. PubMed ID: 28561230 [No Abstract] [Full Text] [Related]
10. Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro. Colombo M; Figueiró F; de Fraga Dias A; Teixeira HF; Battastini AMO; Koester LS Int J Pharm; 2018 May; 543(1-2):214-223. PubMed ID: 29605695 [TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting. Kumbhar SA; Kokare CR; Shrivastava B; Gorain B; Choudhury H Int J Pharm; 2020 Aug; 586():119499. PubMed ID: 32505580 [TBL] [Abstract][Full Text] [Related]
12. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia. Ahmad N; Ahmad R; Alam MA; Ahmad FJ Drug Res (Stuttg); 2018 Oct; 68(10):584-595. PubMed ID: 29669380 [TBL] [Abstract][Full Text] [Related]
13. Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion. Abdou EM; Kandil SM; Miniawy HMFE Int J Pharm; 2017 Aug; 529(1-2):667-677. PubMed ID: 28729175 [TBL] [Abstract][Full Text] [Related]
14. Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies. Parikh RH; Patel RJ Curr Drug Deliv; 2016; 13(7):1130-1143. PubMed ID: 26638977 [TBL] [Abstract][Full Text] [Related]
15. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel. Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562 [No Abstract] [Full Text] [Related]
16. Enhancement in brain uptake of vitamin D Kumar M; Nishad DK; Kumar A; Bhatnagar A; Karwasra R; Khanna K; S K; Sharma D; Dua K; Mudaliyar V; Sharma N J Microencapsul; 2020 Nov; 37(7):492-501. PubMed ID: 32715833 [TBL] [Abstract][Full Text] [Related]
17. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting. Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122 [TBL] [Abstract][Full Text] [Related]
18. Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation. Pandey YR; Kumar S; Gupta BK; Ali J; Baboota S Nanotechnology; 2016 Jan; 27(2):025102. PubMed ID: 26629830 [TBL] [Abstract][Full Text] [Related]
19. Lipid nanocarrier of selegiline augmented anti-Parkinson's effect via P-gp modulation using quercetin. Qamar Z; Ashhar MU; Annu ; Qizilibash FF; Sahoo PK; Ali A; Ali J; Baboota S Int J Pharm; 2021 Nov; 609():121131. PubMed ID: 34563617 [TBL] [Abstract][Full Text] [Related]
20. Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability. Tran TH; Guo Y; Song D; Bruno RS; Lu X J Pharm Sci; 2014 Mar; 103(3):840-52. PubMed ID: 24464737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]